找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Experimental and Applied Immunotherapy; Jeffrey Medin,Daniel Fowler Book 2011 Springer Science+Business Media, LLC 2011 Cancer.Immunothera

[復制鏈接]
樓主: 搖尾乞憐
31#
發(fā)表于 2025-3-26 21:50:53 | 只看該作者
Dendritic Cell-Based Cancer Vaccines: Practical Considerationsions of cell-based immunotherapy. Specific issues include optimization and standardization of cell specific products, identification of ideal patients and cancer subtypes as well as methods to comprehensively evaluate the host response and more fully understand underlying biological effectors that are engaged.
32#
發(fā)表于 2025-3-27 02:15:16 | 只看該作者
Negative Regulators in Cancer Immunology and Immunotherapy and immunotherapy. In this chapter, we describe some of these immunosuppressive mechanisms and components that are linked in complex networks. A better understanding of these mechanisms will eventually lead to improvements of cancer immunotherapies.
33#
發(fā)表于 2025-3-27 06:46:52 | 只看該作者
34#
發(fā)表于 2025-3-27 10:35:47 | 只看該作者
Combining Cancer Vaccines with Conventional Therapiesese issues and results from recent experiments demonstrating the combining vaccination with surgical resection or chemotherapy can greatly enhance the activity of cancer vaccines in situations of large tumor burden.
35#
發(fā)表于 2025-3-27 15:39:50 | 只看該作者
Extending the Use of Adoptive T Cell Immunotherapy for Infections and Cancerections (e.g., cytomegalovirus [CMV], Epstein-Barr virus [EBV], and adenovirus) and virus-associated diseases, such as EBV-associated lymphoproliferative disease (LPD), that arise in the immunocompromised host. This therapeutic approach has also been extended to the treatment of cancer and has shown
36#
發(fā)表于 2025-3-27 21:00:16 | 只看該作者
B Lymphocytes in Cancer Immunologys with solid tumors harbor circulating antitumor antibodies and most tumors contain a population of infiltrating B cells implying an association between oncogenic events and B-cell activation. B-cell immunity can be beneficial by providing antibody-mediated protection from oncogenic viruses or a sou
37#
發(fā)表于 2025-3-27 23:30:25 | 只看該作者
38#
發(fā)表于 2025-3-28 03:22:36 | 只看該作者
Natural Killer Cells for Cancer Immunotherapyatively underrepresented in the medical literature, due in part to the strong emphasis placed on studying the mechanisms of the antigenic specificity and memory of T and B lymphocytes. Fortunately, as innate cells have gained prominence in recent years, NK cell research has blossomed and we now have
39#
發(fā)表于 2025-3-28 07:02:33 | 只看該作者
40#
發(fā)表于 2025-3-28 14:05:58 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 13:57
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
康马县| 陆丰市| 丹巴县| 祁东县| 芜湖县| 那坡县| 汤原县| 梓潼县| 大邑县| 天门市| 北京市| 女性| 宜丰县| 伊宁县| 南溪县| 鸡泽县| 铜陵市| 济源市| 贞丰县| 重庆市| 资阳市| 宽城| 漳州市| 化德县| 蒙阴县| 丰顺县| 六盘水市| 仪陇县| 渑池县| 桑日县| 英吉沙县| 无棣县| 乌兰浩特市| 博湖县| 盈江县| 澄城县| 延川县| 鲁山县| 甘泉县| 涟源市| 抚顺县|